Geographic Atrophy Long-Terms Outcomes Study

CompletedOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Geographic Atrophy
Trial Locations (5)

20157

Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milan

48149

Universitaetsklinikum Muenster, Münster

69004

Centre Hospitalier de la Croix Rousse, Lyon

NSW 2145

Sydney West Retina, Westmead

BT14 6AB

Belfast Health & SC Trust, Belfast

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Apellis Pharmaceuticals, Inc.

INDUSTRY